June 13 - 14, 2017
The New York Academy of Sciences
Presented by Eli Lilly and Company and the New York Academy of Sciences
This 2-day convening will bring together leading researchers, clinicians, industry, and governmental stakeholders from around the world to explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries. Plenary sessions will be designed to present emerging basic and clinical research in the following areas: neurodegenerative disease-modifying therapies that slow progression; mechanisms of neuroplasticity, including the role of dendritic spines, axonal growth, synaptic plasticity, inflammation, oxidative stress, mitochondrial function, and autophagy; glial function in the central nervous system; cutting-edge strategies to promote and modify neurogenesis; and biomarker and imaging modalities for neuroregeneration. The conference will conclude with an interactive panel discussion exploring future directions, critical open questions, and promising therapies in the field of neuroregeneration and neurorestoration.